The standard semaglutide titration protocol — starting at 0.25 mg weekly and escalating to maintenance doses — is well established for GLP-1 weight loss therapy. However, some patients and prescribers have explored the concept of "microdosing" — maintaining lower doses intentionally to minimize side effects while preserving meaningful weight loss benefits. Understanding what this approach offers, its limitations, and why physician supervision is essential is important for anyone considering it.
What Is Semaglutide Microdosing?
Microdosing in the context of semaglutide typically refers to maintaining doses at the lower end of the therapeutic range — often 0.25 mg to 1 mg weekly — rather than escalating to the standard 2.4 mg maintenance dose used in the STEP weight loss trials. Proponents suggest that lower doses can significantly reduce nausea, vomiting, and gastrointestinal side effects while still producing meaningful appetite reduction and weight loss. This approach may particularly appeal to patients who experienced intolerable side effects at higher doses.
What the Evidence Shows
Clinical trial data on semaglutide for weight loss are predominantly at higher doses (2.4 mg weekly for Wegovy). Lower doses do produce weight loss — but typically less total weight reduction than maximally titrated doses. A patient maintaining at 0.5 mg might lose 8–12% of body weight compared to the 15–20% seen at 2.4 mg. Whether this trade-off is acceptable depends on individual goals, baseline weight, and side effect tolerance.
- Lower doses reduce but do not eliminate nausea and GI side effects for most patients
- Weight loss response is dose-dependent — lower dose generally means less total loss
- Some patients find a "sweet spot" dose that balances tolerability and efficacy
- Long-term data on lower-dose maintenance protocols are still accumulating
Why Physician Guidance Is Essential
Adjusting semaglutide dosing outside standard protocols should always be done in consultation with a physician, not based on online advice. Dr. Arpana Pillay at Vish Medical works with each patient to find the optimal titration schedule, manage side effects proactively, and adjust the plan based on your individual response. Book a GLP-1 consultation to discuss the right approach for your weight loss goals.